An optimised, rapid chromogenic assay, specific for measuring direct factor Xa inhibitors (rivaroxaban) in plasma.
Samama
Meyer Michel
MM
Amiral
Jean
J
Guinet
Céline
C
Perzborn
Elisabeth
E
Depasse
François
F
D001777:Blood Coagulation / Q000187:drug effects*; D017322:Clinical Trials, Phase II as Topic; D003124:Colorimetry; D004305:Dose-Response Relationship, Drug; D016903:Drug Monitoring / Q000379:methods*; D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents / Q000097:blood*; D006801:Humans; D008297:Male; D009025:Morpholines / Q000097:blood*; D019637:Orthopedic Procedures / Q000009:adverse effects; D011237:Predictive Value of Tests; D000069552:Rivaroxaban; D013876:Thiophenes / Q000097:blood*; D013927:Thrombosis / Q000097:blood / Q000209:etiology / Q000517:prevention & control
D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents; D009025:Morpholines; D013876:Thiophenes; D000069552:Rivaroxaban